Literature DB >> 6695688

Decreased systolic wall thickening in myocardium adjacent to ischemic zones in conscious swine during brief coronary artery occlusion.

B D Guth, F C White, K P Gallagher, C M Bloor.   

Abstract

The purpose of this study was to examine wall thickening in normally perfused myocardium adjacent to acutely ischemic zones. Regional wall thickening (%WT), internal minor axis diameter, and hemodynamics were monitored in nine conscious swine during temporary occlusion of the left circumflex coronary artery (LCCA). Animals were chronically instrumented with ultrasonic dimension gauges for measuring left ventricular (LV) wall thickness and minor axis, catheters in the left atrium and aorta, and a pneumatic occluder around the proximal LCCA. During a 2-minute occlusion of the LCCA, radiolabeled tracer microspheres (10 micron) were injected into the left atrium to determine regional myocardial blood flow (RMBF). Within the ischemic zone, reduction of %WT was related linearly (Y = 24.9 X -4.1, p less than 0.001) to reduced RMBF and endocardial/epicardial blood flow ratio was reduced from 1.30 +/- 0.12 (mean +/- SE) to 0.87 +/- 0.11 (p less than 0.01). In zones adjacent to the ischemic zones RMBF was unchanged by LCCA occlusion. RMBF and %WT were poorly correlated (r = 0.38) and endocardial/epicardial blood flow ratio was unchanged from preocclusion values. Therefore, myocardium adjacent to ischemic zones may have reduced thickening despite no apparent blood flow changes. We conclude that such dysfunction may be due to either mechanical tethering effects or a reduction of global LV function due to the presence of an acutely ischemic zone.

Entities:  

Mesh:

Year:  1984        PMID: 6695688     DOI: 10.1016/0002-8703(84)90086-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

Review 1.  Regional myocardial mechanics: integrative computational models of flow-function relations.

Authors:  A D McCulloch; R Mazhari
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

2.  Detection of myocardial viability in acute infarction using contrast-enhanced (1)H magnetic resonance imaging.

Authors:  H B Hillenbrand; J Sandstede; C Lipke; H Köstler; T Pabst; E Werner; G Ertl; D Hahn; W R Bauer
Journal:  MAGMA       Date:  2003-09-30       Impact factor: 2.310

3.  Myocardial protection during surgical intervention for treatment of acute myocardial infarction.

Authors:  F Beyersdorf; G D Buckberg
Journal:  Tex Heart Inst J       Date:  1992

4.  Recruitment of a time-dependent inotropic reserve by postextrasystolic potentiation in normal and reperfused myocardium.

Authors:  S Schäfer; G Heusch
Journal:  Basic Res Cardiol       Date:  1990 May-Jun       Impact factor: 17.165

5.  Discrepancies between myocardial blood flow and fiber shortening in the ischemic border zone as assessed with video mapping of epicardial deformation.

Authors:  F W Prinzen; T Arts; A P Hoeks; R S Reneman
Journal:  Pflugers Arch       Date:  1989-11       Impact factor: 3.657

6.  Characterization of nonischemic segment shortening during variable extent of myocardial ischemia in conscious dogs.

Authors:  M Fujita; A Mikuniya; D P McKown; M D McKown; D Franklin
Journal:  Heart Vessels       Date:  1987       Impact factor: 2.037

7.  Detecting myocardial ischemia at rest with cardiac phase-resolved blood oxygen level-dependent cardiovascular magnetic resonance.

Authors:  Sotirios A Tsaftaris; Xiangzhi Zhou; Richard Tang; Debiao Li; Rohan Dharmakumar
Journal:  Circ Cardiovasc Imaging       Date:  2012-12-18       Impact factor: 7.792

Review 8.  The relationship between regional blood flow and contractile function in normal, ischemic, and reperfused myocardium.

Authors:  G Heusch
Journal:  Basic Res Cardiol       Date:  1991 May-Jun       Impact factor: 17.165

Review 9.  Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents.

Authors:  G Heusch
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.